Medical School:
Department: Neurology
- MD, University of Rochester School of Medicine and Dentistry (2003)
- BA, Allegheny College (PA) (1999)
- University of Vermont Program (2004)
- University of Vermont Program, Chief Resident, Neurology (2007)
- Memorial Sloan-Kettering Cancer Center Program, Neuro-Oncology (2009)
Department: Neurology
Professional Titles
- Professor of Neurology and Neurosurgery
- Program Director, Neurology Residency Program
- Vice-Chair Education, Department of Neurology
Publications
- David KA, Sundaram S, Kim SH, Vaca R, Lin Y, Singer S, Malecek MK, Carter J, Zayac A, Kim MS, Reddy N, Ney D, Habib A, Strouse C, Graber J, Bachanova V, Salman S, Vendiola JA, Hossain N, Tsang M, Major A, Bond DA, Agrawal P, Mier-Hicks A, Torka P, Rajakumar P, Venugopal P, Berg S, Glantz M, Goldlust SA, Folstad M, Kumar P, Ollila TA, Cai J, Spurgeon S, Sieg A, Cleveland J, Chang J, Epperla N, Karmali R, Naik S, Martin P, Smith SM, Rubenstein J, Kahl B, Evens AM. Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers. Am J Hematol. 2023 Jun;98(6):900-912. PubMed PMID: 36965007
- Agrawal P, David KA, Chen Z, Sundaram S, Kim SH, Vaca R, Lin Y, Singer S, Malecek MK, Carter J, Zayac A, Kim MS, Reddy N, Ney D, Habib A, Strouse C, Graber J, Bachanova V, Salman S, Vendiola JA, Hossain N, Tsang M, Major A, Gandhi MK, Keane C, Bond DA, Folstad M, Chang J, Mier-Hicks A, Torka P, Rajakumar P, Venugopal P, Berg S, Glantz M, Goldlust SA, Matnani R, Kumar P, Ollila TA, Cai J, Spurgeon SE, Sieg AG, Cleveland J, Epperla N, Karmali R, Naik S, Smith SM, Rubenstein JL, Kahl BS, Chadburn A, Evens AM, Martin P. EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort. Leuk Lymphoma. 2023 May;64(5):1026-1034. PubMed PMID: 36960939
- Boumaza X, Bonneau B, Roos-Weil D, Pinnetti C, Rauer S, Nitsch L, Del Bello A, Jelcic I, Sühs KW, Gasnault J, Goreci Y, Grauer O, Gnanapavan S, Wicklein R, Lambert N, Perpoint T, Beudel M, Clifford D, Sommet A, Cortese I, Martin-Blondel G. Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors. Ann Neurol. 2023 Feb;93(2):257-270. PubMed PMID: 36151879
- Shiao JC, Wolf AB, Rabinovitch RA, Smith C, Kleinschmidt-DeMasters BK, Ney DE. Long-Term Control of Primary Cerebral ALH Amyloidoma With Focal Radiation Therapy. Adv Radiat Oncol. 2022 Mar-Apr;7(2):100831. PubMed PMID: 34934868
- Schindler SE, Ney DE, Goss AL, Rabinovici G. ANA Investigates: The Future of Biomarkers in Alzheimer Disease. Ann Neurol. 2022 Aug;92(2):159-160. PubMed PMID: 35689567
- Mohile NA, Messersmith H, Gatson NT, Hottinger AF, Lassman A, Morton J, Ney D, Nghiemphu PL, Olar A, Olson J, Perry J, Portnow J, Schiff D, Shannon A, Shih HA, Strowd R, van den Bent M, Ziu M, Blakeley J. Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline. J Clin Oncol. 2022 Feb 1;40(4):403-426. PubMed PMID: 34898238
- Mohile NA, Messersmith H, Gatson NT, Hottinger AF, Lassman A, Morton J, Ney D, Nghiemphu PL, Olar A, Olson J, Perry J, Portnow J, Schiff D, Shannon A, Shih HA, Strowd R, van den Bent M, Ziu M, Blakeley J. Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline. J Clin Oncol. 2022 Feb 1;40(4):403-426. PubMed PMID: 34898238
- Boumaza X, Bonneau B, Roos-Weil D, Pinnetti C, Rauer S, Nitsch L, Del Bello A, Jelcic I, Sühs KW, Gasnault J, Goreci Y, Grauer O, Gnanapavan S, Wicklein R, Lambert N, Perpoint T, Beudel M, Clifford D, Sommet A, Cortese I, Martin-Blondel G. Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors. Ann Neurol. 2022 Sep 24. [Epub ahead of print] PubMed PMID: 36151879
- Fakhoury KR, Ney DE, Ormond DR, Rusthoven CG. Immunotherapy and radiation for high-grade glioma: a narrative review. Transl Cancer Res 2021;10(5):2537-2570.
- Caroline Goldin and Douglas Ney. Primary Central Nervous System Lymphoma. Medscape Drugs and Diseases. Updated July 6, 2021.
- Fakhoury KR, Ney DE, Ormond DR, Rusthoven CG. Immunotherapy and radiation for high-grade glioma: a narrative review. Transl Cancer Res. 2021 May;10(5):2537-2570. PubMed PMID: 35116570
- Daniel EB, Ney DE, Mulcahy Levy JM. MEK inhibition with trametinib is a successful therapy in ganglioglioma. Clinical Case Reports and Reviews. 2020, Volume 6; 1-2.
- Kapadia RK, Ney D. Stabilization of Progressive Multifocal Leukoencephalopathy After Pembrolizumab Treatment. Neurohospitalist. 2020 Jul;10(3):238-239. PubMed PMID: 32549952
- Kapadia RK, Ney DE, Hannan M, Farley M, Pastula DM, Piquet AL. Glial fibrillary acidic protein (GFAP) associated autoimmune meningoencephalitis in a patient receiving nivolumab. J Neuroimmunol. 2020 Jul 15;344:577259. PubMed PMID: 32416558
- Mohile NA, Blakeley JO, Gatson NTN, Hottinger AF, Lassman AB, Ney DE, Olar A, Schiff D, Shih HA, Strowd R, van den Bent MJ, Ziu M. Urgent Considerations for the Neuro-oncologic Treatment of Patients with Gliomas During the COVID-19 Pandemic. Neuro Oncol. 2020 Apr 11. [Epub ahead of print] PubMed PMID: 32277236
- Daniel EB, Ney DE, Levy JMM. MEK inhibition with trametinib is a successful therapy in ganglioglioma. Clin Case Rep Rev. 2020 Jun;6(2). PubMed PMID: 32999736
- Khan M, Ney DE, Kleinschmidt-DeMasters BK, Horton L, Alvarez E, Piquet AL. CNS atypical T-cell lymphoproliferative disease following treatment with alemtuzumab. Neurol Clin Pract. 2019 Jun;9(3):273-276. PubMed PMID: 31341717
- Johnson PD, Sillau S, Masdeu JC, Ney DE, Korb PJ. Education Research: Neuroradiology curriculum in neurology residency training programs: How we teach neuroimaging. Neurology. 2019 Jan 22;92(4):199-203. PubMed PMID: 30665912
- Kluger BM, Ney DE, Bagley SJ, Mohile N, Taylor LP, Walbert T, Jones CA. Top Ten Tips Palliative Care Clinicians Should Know When Caring for Patients with Brain Cancer. J Palliat Med. 2019 Oct 15. [Epub ahead of print] PubMed PMID: 31613698
- Ung TH, Ney DE, Damek D, Rusthoven CG, Youssef AS, Lillehei KO, Ormond DR. The Neurologic Assessment in Neuro-Oncology (NANO) Scale as an Assessment Tool for Survival in Patients With Primary Glioblastoma. Neurosurgery. 2019 Mar 1;84(3):687-695. PubMed PMID: 29618103
- Oushy S, Sillau SH, Ney DE, Damek DM, Youssef AS, Lillehei KO, Ormond DR. New-onset seizure during and after brain tumor excision: a risk assessment analysis. J Neurosurg. 2018 Jun;128(6):1713-1718. PubMed PMID: 28753117
- Ung TH, Ney DE, Damek D, Rusthoven CG, Youssef AS, Lillehei KO, Ormond DR. The Neurologic Assessment in Neuro-Oncology (NANO) Scale as an Assessment Tool for Survival in Patients With Primary Glioblastoma. Neurosurgery. 2018 Mar 30. [Epub ahead of print] PubMed PMID: 29618103
- Oushy S, Sillau SH, Ney DE, Damek DM, Youssef AS, Lillehei KO, Ormond DR. New-onset seizure during and after brain tumor excision: a risk assessment analysis. J Neurosurg. 2017 Jul 28;:1-6. [Epub ahead of print] PubMed PMID: 28753117
- Romero M, González-Fontal GR, Saavedra C, Guerra J, Quintero G, Quijano S, Ney D, Henao-Martínez AF. Primary CNS plasmablastic lymphoma in an HIV/EBV negative patient: A case report. Diagn Cytopathol. 2016 Jan;44(1):61-5. PubMed PMID: 26468050
- Rusthoven CG, Koshy M, Sher DJ, Ney DE, Gaspar LE, Jones BL, Karam SD, Amini A, Ormond DR, Youssef AS, Kavanagh BD. Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis. JAMA Neurol. 2016 Jul 1;73(7):821-8. PubMed PMID: 27214765
- Romero M, González-Fontal GR, Saavedra C, Guerra J, Quintero G, Quijano S, Ney D, Henao-Martínez AF. Primary CNS plasmablastic lymphoma in an HIV/EBV negative patient: A case report. Diagn Cytopathol. 2016 Jan;44(1):61-5. PubMed PMID: 26468050
- Ney DE, Carlson JA, Damek DM, Gaspar LE, Kavanagh BD, Kleinschmidt-DeMasters BK, Waziri AE, Lillehei KO, Reddy K, Chen C. Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma. J Neurooncol. 2015 Mar;122(1):135-43. PubMed PMID: 25524817
- Carlson JA, Reddy K, Gaspar LE, Ney D, Kavanagh BD, Damek D, Lillehei K, Chen C. Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials. J Neurooncol. 2015 Jun;123(2):251-7. PubMed PMID: 25920710
- Schowinsky J, Leppert M, Ney D, Kleinschmidt-DeMasters BK. Prominent Vascular and Perivascular Eosinophilic Infiltrates Heralding CNS Mycosis Fungoides. J Neuropathol Exp Neurol. 2015 Oct;74(10):948-51. PubMed PMID: 26352990
- Ney DE, Carlson JA, Damek DM, Gaspar LE, Kavanagh BD, Kleinschmidt-DeMasters BK, Waziri AE, Lillehei KO, Reddy K, Chen C. Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma. J Neurooncol. 2014 Dec 19. [Epub ahead of print] PubMed PMID: 25524817
- Ney DE, Messersmith W, Behbakht K. Anti-ma2 paraneoplastic encephalitis in association with recurrent cervical cancer. J Clin Neurol. 2014 Jul;10(3):262-6. PubMed PMID: 25045381
- Reddy K, Gaspar LE, Kavanagh BD, Waziri A, Damek DM, Ney D, Lillehei KO, Chen C. Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide. J Neurooncol. 2013 Aug;114(1):111-6. PubMed PMID: 23729276
- Reddy K, Gaspar LE, Kavanagh BD, Waziri A, Damek DM, Ney D, Lillehei KO, Chen C. Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide. J Neurooncol. 2013 Aug;114(1):111-6. PubMed PMID: 23729276
- Wolf AB, Shiao JC, Rabinovitch RA, Schowinsky JT, Smith C, Kleinschmidt-DeMasters BK, Ney DE. Long-term control of primary cerebral ALH amyloidoma with focal radiation therapy. Advances in radiation Oncology. Submitted April 2021.
- Mohile N, Messersmith H, Gatson N, Hottinger A, Lassman A, Morton J, Ney DE, et al. Therapy for Diffuse Astrocytic and Oligodendroglial Tumors: ASCO-SNO Guidelines. J Clin Oncol. Submitted July 2021.
- Agrawal P, David KA, Chen Z, Sundaram S, Kim SH, Vaca R, Lin Y, Singer S, Malecek MK, Carter J, Zayac A, Kim M, Reddy N, Ney DE, et al. EBV-positive primary CNS lymphomas in older patientsL incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort. Annals Oncology. Submitted August 2021
Practice Locations
University of Colorado Cancer Center - Anschutz Medical Campus
1665 Aurora Ct
Aurora, CO 80045
720-848-0300
UCHealth Brain and Spine Tumor Multidisciplinary Clinic - Anschutz Medical Campus
1665 Aurora Court, Anschutz Cancer Pavilion, 2nd Floor, Suite 2004
Aurora, CO 80045
720-848-0300
Hospital Affiliation
1665 Aurora Ct
Aurora, CO 80045
720-848-0300
UCHealth Brain and Spine Tumor Multidisciplinary Clinic - Anschutz Medical Campus
1665 Aurora Court, Anschutz Cancer Pavilion, 2nd Floor, Suite 2004
Aurora, CO 80045
720-848-0300
Hospital Affiliation
- University of Colorado Hospital
Specialty Information
Specialties
- Neurology, Board Certification (2008, 2018)
- Neuro-Oncology
- United Council of Neurologic Subspecialties Certification in Neuro-Oncology, Board Certification (2013)
- Brain and Nervous System - Brain Tumors
- Cancers - Brain Cancer
- Brain and Nervous System
- Cancers
Clinical Interests
Primary brain tumors, metastatic brain tumors, primary central nervous system lymphoma, paraneoplastic disorders, neurologic complications of cancer
Primary brain tumors, metastatic brain tumors, primary central nervous system lymphoma, paraneoplastic disorders, neurologic complications of cancer
General Information
Medical Schools:
- MD, University of Rochester School of Medicine and Dentistry (2003)
Undergraduate Schools:
- BA, Allegheny College (PA) (1999)
Internships:
- University of Vermont Program (2004)
Residency Programs:
- University of Vermont Program, Chief Resident, Neurology (2007)
Fellowships:
- Memorial Sloan-Kettering Cancer Center Program, Neuro-Oncology (2009)
Department: Neurology